briumvi
neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.
vardenafil "sanoswiss" 10 mg tabletter
uab sanoswiss - vardenafilhydrochloridtrihydrat - tabletter - 10 mg
nicorandil "rivopharm" 20 mg tabletter
rivopharm limited - nicorandil - tabletter - 20 mg
toujeo (previously optisulin)
sanofi-aventis deutschland gmbh - insulin glargin - diabetes mellitus - narkotika anvendt i diabetes - behandling af diabetes mellitus hos voksne, unge og børn fra 6 år.
lamotrigin "teva" 100 mg tabletter
teva b.v. - lamotrigin - tabletter - 100 mg
lamotrigin "teva" 200 mg tabletter
teva b.v. - lamotrigin - tabletter - 200 mg
lamotrigin "teva" 50 mg tabletter
teva b.v. - lamotrigin - tabletter - 50 mg
nicorandil "rivopharm" 10 mg tabletter
rivopharm limited - nicorandil - tabletter - 10 mg
lamotrigin "1a farma" 100 mg tabletter
1a farma a/s - lamotrigin - tabletter - 100 mg
lamotrigin "1a farma" 200 mg tabletter
1a farma a/s - lamotrigin - tabletter - 200 mg